Common Stock, Shares, Outstanding of Sigyn Therapeutics, Inc. from 31 Dec 2014 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Sigyn Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2014 to 30 Sep 2025.
  • Sigyn Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 1,605,377, a 13% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Sigyn Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 1,605,377 +184,699 +13% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 1,605,377 +341,724 +27% 30 Jun 2025 10-Q 05 Sep 2025 2025 Q2
Q1 2025 1,605,377 +380,550 +31% 31 Mar 2025 10-Q 20 May 2025 2025 Q1
Q4 2024 1,605,377 +316,962 +25% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 1,420,678 -42,815,582 -97% 30 Sep 2024 10-Q 19 Nov 2024 2024 Q3
Q2 2024 1,263,653 -42,967,749 -97% 30 Jun 2024 10-Q 19 Aug 2024 2024 Q2
Q1 2024 1,224,827 -41,579,998 -97% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 1,288,415 +331,820 +35% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q3 2023 44,236,260 +6,940,447 +19% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 44,231,402 +6,935,589 +19% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 42,804,825 +5,509,022 +15% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 956,595 -36,339,218 -97% 31 Dec 2022 10-K 20 Feb 2024 2023 FY
Q3 2022 37,295,813 +567,010 +1.5% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 37,295,813 +671,157 +1.8% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 37,295,803 +2,047,290 +5.8% 31 Mar 2022 10-Q 13 May 2022 2022 Q1
Q4 2021 37,295,813 +2,094,300 +5.9% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 36,728,803 +36,228,803 +7246% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 36,624,656 -59,147,752 -62% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 35,248,513 -57,190,561 -62% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 35,201,513 +34,701,513 +6940% 31 Dec 2020 10-K 21 Mar 2022 2021 FY
Q3 2020 500,000 -80,772,408 -99% 30 Sep 2020 8-K/A 30 Dec 2020
Q2 2020 95,772,408 +14,500,000 +18% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 92,439,074 +11,166,666 +14% 31 Mar 2020 10-Q 15 May 2020 2020 Q1
Q4 2019 500,000 -80,772,408 -99% 31 Dec 2019 10-Q 17 May 2021 2021 Q1
Q3 2019 81,272,408 +10,650,000 +15% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 81,272,408 +18,450,000 +29% 30 Jun 2019 10-Q 05 Aug 2019 2019 Q2
Q1 2019 81,272,408 +21,766,750 +37% 31 Mar 2019 10-Q 19 Apr 2019 2019 Q1
Q4 2018 81,272,408 +27,995,732 +53% 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q3 2018 70,622,408 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 62,822,408 30 Jun 2018 10-Q 13 Aug 2018 2018 Q2
Q1 2018 59,505,658 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q4 2017 53,276,676 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q3 2016 34,481,333 +4,626,333 +15% 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 34,398,000 30 Jun 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 34,323,000 31 Mar 2016 10-Q 09 May 2016 2016 Q1
Q4 2015 34,323,000 +18,322,750 +115% 31 Dec 2015 10-Q 14 Nov 2016 2016 Q3
Q3 2015 29,855,000 30 Sep 2015 10-Q 21 Dec 2015 2015 Q3
Q4 2014 16,000,250 31 Dec 2014 10-Q 09 Nov 2020 2020 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.